The Susceptibility of <i>Klebsiella Pneumoniae</i> Strains Isolated from COVID-19 Patients to Commercially Available Bacteriophage Medications

The Susceptibility of <i>Klebsiella Pneumoniae</i> Strains Isolated from COVID-19 Patients to Commercially Available Bacteriophage Medications

Background. Superinfection caused by Klebsiella pneumoniae occupies a leading position in the structure of bacterial complications in COVID-19 patients. The intensive circulation of Klebsiella in specialised hospitals has contributed to the consolidation of the most clinically and epidemiologically...

Full description

Saved in:
Bibliographic Details
Main Authors: B. I. Aslanov, A. E. Goncharov, S. D. Konev, A. S. Mochov, D. A. Azarov, E. А. Lebedeva, A. V. Kuleshova, V. V. Kolodzhieva, E. N. Kolosovskaya, A. M. Nifontova, D, A. Lioznov
Format: Article
Language:Russian
Published: LLC "Publishing House OKI" 2025-04-01
Series:Антибиотики и Химиотерапия
Subjects:
klebsiella pneumoniae
phage therapy
covid-19
sensitivity to bacteriophages
spot test
Online Access:https://www.antibiotics-chemotherapy.ru/jour/article/view/1206
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.antibiotics-chemotherapy.ru/jour/article/view/1206

Similar Items